Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation
- 28 February 1995
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 33 (2) , 231-236
- https://doi.org/10.1016/0168-3659(94)00096-d
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Patent Literature Review of Ophthalmic InsertsDrug Development and Industrial Pharmacy, 1995
- The Effect of Reduced Eyedrop Size and Eyelid Closure on the Therapeutic Index of PhenylephrineAmerican Journal of Ophthalmology, 1993
- Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicinAlbrecht von Graefes Archiv für Ophthalmologie, 1993
- Topical and intravenous gentamicin in traumatically lacerated eyesAlbrecht von Graefes Archiv für Ophthalmologie, 1992
- Reformulation and Drop Size of Apraclonidine HydrochlorideAmerican Journal of Ophthalmology, 1992
- An Assistive Eye-Drop MoldAmerican Journal of Occupational Therapy, 1991
- A study of the causes of non-compliance by patients prescribed eyedrops.British Journal of Ophthalmology, 1990
- Ocular inserts for controlled release of antibioticsBiomaterials, 1983
- Concentration of Gentamicin in Experimental Corneal UlcersArchives of Ophthalmology (1950), 1974